161 related articles for article (PubMed ID: 38026524)
1. Preparation and Characterization Evaluation of Poly(L-Glutamic Acid)-
Guo D; Huang Y; Wang K; Yang C; Ma L; Zhang Y; Yu H; Cui M; Tang Z
Int J Nanomedicine; 2023; 18():6901-6914. PubMed ID: 38026524
[TBL] [Abstract][Full Text] [Related]
2. Formula optimization and in vivo study of poly(L-glutamic acid)-g-methoxy poly(ethylene glycol)/combretastatin A4/BLZ945 nanoparticles for cancer therapy.
Huang Y; Yang C; Lv J; Zhang Y; Wang K; Ma L; Liu Z; Yu H; Li M; Tang Z
Int J Pharm; 2023 Apr; 636():122849. PubMed ID: 36933582
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects and underlying mechanism of poly (L-glutamic acid)-
Chen J; Yin M; Yang C; Wang K; Ma L; Yu H; Huang Y; Liu F; Tang Z
Front Bioeng Biotechnol; 2024; 12():1336692. PubMed ID: 38375454
[No Abstract] [Full Text] [Related]
4. Poly(L-Glutamic Acid)-Drug Conjugates for Chemo- and Photodynamic Combination Therapy.
Yu H; Bao Y; Xu C; Chen L; Tang Z
Macromol Biosci; 2021 Jan; 21(1):e2000192. PubMed ID: 33043592
[TBL] [Abstract][Full Text] [Related]
5. A UHPLC-MS/MS method coupled with simple and efficient alkaline hydrolysis for free and total determination of conjugate nanomedicine: Pharmacokinetic and biodistribution study of poly (l-glutamic acid)-graft-methoxy poly (ethylene glycol)/combretastatin A4.
Zeng Q; Liu Y; Song Y; Feng B; Xu P; Shan B; Liao Z; Liu K; Zhong Y; Chen L; Su D
J Pharm Biomed Anal; 2019 May; 169():215-224. PubMed ID: 30877933
[TBL] [Abstract][Full Text] [Related]
6. Co-administration of combretastatin A4 nanoparticles and sorafenib for systemic therapy of hepatocellular carcinoma.
Wang Y; Yu H; Zhang D; Wang G; Song W; Liu Y; Ma S; Tang Z; Liu Z; Sakurai K; Chen X
Acta Biomater; 2019 Jul; 92():229-240. PubMed ID: 31100462
[TBL] [Abstract][Full Text] [Related]
7. Enhanced anti-PD-1 therapy in hepatocellular carcinoma by tumor vascular disruption and normalization dependent on combretastatin A4 nanoparticles and DC101.
Bao X; Shen N; Lou Y; Yu H; Wang Y; Liu L; Tang Z; Chen X
Theranostics; 2021; 11(12):5955-5969. PubMed ID: 33897892
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of combretastatin A4 nanoparticles and anti-PD-L1 for synergistic therapy of hepatocellular carcinoma.
Zhao B; Dong Z; Liu W; Lou F; Wang Q; Hong H; Wang Y
J Nanobiotechnology; 2021 May; 19(1):124. PubMed ID: 33933077
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
[TBL] [Abstract][Full Text] [Related]
10. FXIIIa substrate peptide decorated BLZ945 nanoparticles for specifically remodeling tumor immunity.
Wei Q; Shen N; Yu H; Wang Y; Tang Z; Chen X
Biomater Sci; 2020 Oct; 8(20):5666-5676. PubMed ID: 33049011
[TBL] [Abstract][Full Text] [Related]
11. Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment.
Shen N; Wu J; Yang C; Yu H; Yang S; Li T; Chen J; Tang Z; Chen X
Nano Lett; 2019 Nov; 19(11):8021-8031. PubMed ID: 31558024
[TBL] [Abstract][Full Text] [Related]
12. Tumor regression and potentiation of polymeric vascular disrupting therapy through reprogramming of a hypoxia microenvironment with temsirolimus.
Yu H; Shen N; Bao Y; Chen L; Tang Z
Biomater Sci; 2020 Jan; 8(1):325-332. PubMed ID: 31714543
[TBL] [Abstract][Full Text] [Related]
13. A poly(l-glutamic acid)-combretastatin A4 conjugate for solid tumor therapy: Markedly improved therapeutic efficiency through its low tissue penetration in solid tumor.
Liu T; Zhang D; Song W; Tang Z; Zhu J; Ma Z; Wang X; Chen X; Tong T
Acta Biomater; 2017 Apr; 53():179-189. PubMed ID: 28167300
[TBL] [Abstract][Full Text] [Related]
14. Water-Soluble Combretastatin A4 Phosphate Orally Delivered via Composite Nanoparticles With Improved Inhibition Effect Toward S180 Tumors.
Shen Y; Wu L; Qiu L
J Pharm Sci; 2017 Oct; 106(10):3076-3083. PubMed ID: 28619603
[TBL] [Abstract][Full Text] [Related]
15. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation.
Yu H; Tang Z; Li M; Song W; Zhang D; Zhang Y; Yang Y; Sun H; Deng M; Chen X
J Biomed Nanotechnol; 2016 Jan; 12(1):69-78. PubMed ID: 27301173
[TBL] [Abstract][Full Text] [Related]
17. Combretastatin A4/poly(
Ou Y; Tang ZH; Sun L; Yu HY; Li J; Zhao MH; Xu H
Asian J Pharm Sci; 2018 Mar; 13(2):191-196. PubMed ID: 32104392
[TBL] [Abstract][Full Text] [Related]
18. Block Copolymer Based Nanoparticles for Theranostic Intervention of Cervical Cancer: Synthesis, Pharmacokinetics, and in Vitro/in Vivo Evaluation in HeLa Xenograft Models.
Dumoga S; Rai Y; Bhatt AN; Tiwari AK; Singh S; Mishra AK; Kakkar D
ACS Appl Mater Interfaces; 2017 Jul; 9(27):22195-22211. PubMed ID: 28608677
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
[TBL] [Abstract][Full Text] [Related]
20. Tumor Microenvironment Remodeling-Mediated Sequential Drug Delivery Potentiates Treatment Efficacy.
Xu Y; Lv J; Liu F; Wang J; Liu Y; Kong C; Li Y; Shen N; Gu Z; Tang Z; Chen X
Adv Mater; 2024 Jun; 36(23):e2312493. PubMed ID: 38444177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
